We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LASA.NSE

Price
17.37
Stock movement down
-0.49 (-2.74%)
Company name
Lasa Supergenerics Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
870.26M
Ent value
1.43B
Price/Sales
0.73
Price/Book
0.96
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-3.78%
1 year return
-32.67%
3 year return
-25.17%
5 year return
-14.40%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

LASA.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF16.24
Price to FCF16.24
Price to EBITDA82.66
EV to EBITDA135.73

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales0.73
Price to Book0.96
EV to Sales1.19

FINANCIALS

Per share

Per share data
Current share count50.10M
EPS (TTM)-4.50
FCF per share (TTM)1.06

Income statement

Income statement data
Revenue (TTM)1.20B
Gross profit (TTM)151.42M
Operating income (TTM)-92.65M
Net income (TTM)-227.18M
EPS (TTM)-4.50
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)12.65%
Operating margin (TTM)-7.74%
Profit margin (TTM)-18.98%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash7.34M
Net receivables0.00
Total current assets393.28M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets1.47B
Accounts payable119.45M
Short/Current long term debt202.38M
Total current liabilities484.80M
Total liabilities566.10M
Shareholder's equity907.16M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)53.59M
Capital expenditures (TTM)0.00
Free cash flow (TTM)53.59M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-25.04%
Return on Assets-15.42%
Return on Invested Capital-20.48%
Cash Return on Invested Capital4.83%

STOCK INFORMATION

Stock chart

Stock price data
Open18.10
Daily high18.50
Daily low17.17
Daily Volume113K
All-time high208.85
1y analyst estimate-
Beta0.52
EPS (TTM)-4.50
Dividend per share-
Ex-div date16 Sep 2022
Next earnings date-

Downside potential

Downside potential data
LASA.NSES&P500
Current price drop from All-time high-91.68%-12.89%
Highest price drop-95.33%-56.47%
Date of highest drop31 Jul 20199 Mar 2009
Avg drop from high-76.96%-11.07%
Avg time to new high208 days12 days
Max time to new high1802 days1805 days
COMPANY DETAILS
LASA.NSE (Lasa Supergenerics Limited) company logo
Marketcap
870.26M
Marketcap category
Small-cap
Description
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, and halquinol, as well as 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.
Employees
77
Website
https://lasalabs.com
Investor relations
-
SEC filings
LASA.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved